clearanc synthesi rate beta patient undergo hemodialysi normal subject retent beta patient undergo hemodialysi beta amyloidosi remov beta renal replac therapi prevent amyloidosi current data beta synthesi rate patient undergo hemodialysi scarc specul much remov necessari synthesi plasma kinet iodin beta patient anuria long-term hemodialysi healthi person control kinet model plasma data two-pool model consist rapid hour distribut phase steep curv plasma metabol clearanc clp synthet rate clp beta steadi state plasma concentr plu beta remov hemodialysi case high flux hemodialysi result clp normal control patient hemodialysi ml/min mean SD ml/min contrast beta synthesi rate patient group mg/kg/day differ normal control mg/kg/day due elev beta plasma concentr patient mg/l vs mg/l find presenc end-stag renal diseas signific impact beta gener rate degre accumul beta patient undergo hemodialysi loss renal excretori function 